Clinical studies recruiting near Ann Arbor

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · University of Michigan Health System - Ann Arbor- Site Numbe · Sanofi · NCT06867094 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Trinity Health Saint Joseph Mercy Hospital Ann Arbor · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Trinity Health Saint Joseph Mercy Hospital Ann Arbor · NRG Oncology · NCT05624996 Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A Myel
Phase 2 · National Cancer Institute (NCI) · NCT07437950 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Alliance for Clinical Trials in Oncology · NCT07321652 Registry for Stage 2 Type 1 Diabetes
Phase N/A · University of Michigan Health System - Ann Arbor- Site Numbe · Sanofi · NCT06481904 EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Phase 1/Phase 2 · VA Ann Arbor Healthcare System, Ann Arbor, MI · VA Office of Research and Development · NCT05467748 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Trinity Health IHA - Obstetrics and Gynecology West Arbor · Alliance for Clinical Trials in Oncology · NCT07091617 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · SWOG Cancer Research Network · NCT06769126 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Trinity Health Saint Joseph Mercy Hospital Ann Arbor · NRG Oncology · NCT05946213 CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
NA · VA Ann Arbor Healthcare System, Ann Arbor, MI · VA Office of Research and Development · NCT05996328 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Trinity Health Saint Joseph Mercy Hospital Ann Arbor · NRG Oncology · NCT05174169 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06931340 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · AbbVie · NCT04928846 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · University of Michigan Rogel Cancer Center · Alliance for Clinical Trials in Oncology · NCT06876714 Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Phase 2 · VA Ann Arbor Healthcare System · Sun Pharmaceutical Industries Limited · NCT05422911 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Trinity Health Saint Joseph Mercy Hospital Ann Arbor · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Veteran's Administration Medical Center - Ann Arbor · Canadian Cancer Trials Group · NCT06592924 Prevail Global Study
NA · University of Michigan Health System - University Hospital · Medtronic Vascular · NCT06535854 Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA
Phase N/A · CathVision ApS · NCT07275151 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · Veterans Affairs Ann Arbor Healthcare System · Boehringer Ingelheim · NCT07472517 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Trinity Health Saint Joseph Mercy Hospital Ann Arbor · NRG Oncology · NCT06748222 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Trinity Health Saint Joseph Mercy Hospital Ann Arbor · NRG Oncology · NCT03180268 Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COA
NA · Wake Forest University Health Sciences · NCT06904391 Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Phase 2 · Alliance for Clinical Trials in Oncology · NCT06632977 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Trinity Health Saint Joseph Mercy Hospital Ann Arbor · Alliance for Clinical Trials in Oncology · NCT04242095 CCM OPEN HF Registry
Phase N/A · University of Michigan · Impulse Dynamics · NCT07112924 WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2 · WISPer Site in Ann Arbor, MI · Mediar Therapeutics · NCT06967805 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · University of Michigan Rogel Cancer Center · National Cancer Institute (NCI) · NCT05256225 A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Te
Phase 2 · University of Michigan Health System - Ann Arbor /ID# 273511 · AbbVie · NCT07023289

Look up another city

Look up another condition